Cargando…
Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
Recent studies have shown that interferon-gamma (IFN-γ) synergizes with IFN-α/β to inhibit the replication of both RNA and DNA viruses. We investigated the effects of IFNs on the replication of two strains of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). While treatment of Ver...
Autores principales: | Sainz, Bruno, Mossel, Eric C., Peters, C.J., Garry, Robert F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111895/ https://www.ncbi.nlm.nih.gov/pubmed/15476870 http://dx.doi.org/10.1016/j.virol.2004.08.011 |
Ejemplares similares
-
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005) -
Synergistic Inhibition of Sars-Coronavirus Replication by Type I and Type II IFN
por: Mossel, Eric C., et al.
Publicado: (2006) -
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
por: Sainz, Bruno, et al.
Publicado: (2006) -
Autoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort(®) devices
por: Thakur, Kunal, et al.
Publicado: (2013) -
Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition
por: Versteeg, Gijs A., et al.
Publicado: (2007)